Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support

Physiological Genomics

Volumn 42, Issue 3, 2010, Pages 397-405

  Schwientek, Patrick ^a,c   Ellinghaus, Peter ^b   Steppan, Sonja ^b,e   D'Urso, Donatella ^b   Seewald, Michael ^b   Kassner, Astrid ^a   Cebulla, Ramona ^a   Schulte Eistrup, Sebastian ^a   Morshuis, Michiel ^a   Röfe, Daniela ^a   El Banayosy, Aly ^a,d   Körfer, Reiner ^a   Milting, Hendrik ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b BAYER PHARMA AG   (Germany)

^c BIELEFELD UNIVERSITY   (Germany)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e Fresenius Medical Care AG   (Germany)

Author keywords

Cardiomyopathy; Mechanical unloading; Remodeling; Reverse remodeling

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; GENE EXPRESSION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HUMAN; HUMAN GENOME; IMPLANTATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RNA ISOLATION; STUDENT T TEST; VENTRICULAR ASSIST DEVICE;

EID: 77955720035     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00030.2010     Document Type: Article

References (42)

1. Altemose GT, Gritsus V, Jeevanandam V, Goldman B, Margulies KB. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 16: 765-773, 1997.
2. Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, Koerner MM, El-Banayosy A, Koerfer R, Holtz J, Zerkowski HR. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100: II216-II223, 1999.
3. Birks EJ, Hall JL, Barton PJ, Grindle S, Latif N, Hardy JP, Rider JE, Banner NR, Khaghani A, Miller LW, Yacoub MH. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 112: I57-I64, 2005.
4. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355: 1873-1884, 2006.
5. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41: 1096-1106, 2003. (Pubitemid 36384894)
6. Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, Bache RJ. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14: 251-260, 2003.
7. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 118: S94-S105, 2008.
8. De Jonge N, van Wichen DF, Schipper ME, Lahpor JR, Gmelig-Meyling FH, Robles de Medina EO, de Weger RA. Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol 39: 963-969, 2002.
9. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97: 2316-2322, 1998.
10. El-Banayosy A, Arusoglu L, Kizner L, Fey O, Sarnowski P, Morshuis M, Milting H, Koertke H, Koerfer R. Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients. J Heart Lung Transplant 20: 209-210, 2001.
11. Fermin DR, Barac A, Lee S, Polster SP, Hannenhalli S, Bergemann TL, Grindle S, Dyke DB, Pagani F, Miller LW, Tan S, dos Remedios C, Cappola TP, Margulies KB, Hall JL. Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure. Circ Cardiovasc Genet 1: 117-125, 2008.
12. Fukamachi K. New technologies for mechanical circulatory support: current status and future prospects of CorAide and MagScrew technologies. J Artif Organs 7: 45-57, 2004.
13. Ge Y, Dudoit S, Speed TP. Resampling-based multiple testing for microarray data analysis. Sociedad de Estadística e Investigación Operativa Test 12: 1-77, 2003. (Pubitemid 36964087)
14. George I, Xydas S, Mancini DM, Lamanca J, DiTullio M, Marboe CC, Shane E, Schulman AR, Colley PM, Petrilli CM, Naka Y, Oz MC, Maybaum S. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 25: 1084-1090, 2006.
15. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28: 613-627, 2007.
16. Hall JL, Grindle S, Han X, Fermin D, Park S, Chen Y, Bache RJ, Mariash A, Guan Z, Ormaza S, Thompson J, Graziano J, de Sam Lazaro SE, Pan S, Simari RD, Miller LW. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17: 283-291, 2004.
17. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102: 2713-2719, 2000.
18. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92: II191-II195, 1995.
19. Kittleson MM, Hare JM. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc Med 15: 130-138, 2005.
20. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21: 299-307, 2005.
21. Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, Parmigiani G, Miller LW, Chen Y, Hall JL, Garcia JG, Hare JM. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110: 3444-3451, 2004.
22. Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol 45: 668-676, 2005.
23. Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112: 364-374, 2005. (Pubitemid 41022077)
24. 2+ ATPase expression. Circulation 113: 2724-2732, 2006.
25. Kuner R, Barth AS, Ruschhaupt M, Buness A, Zwermann L, Kreuzer E, Steinbeck G, Poustka A, Sultmann H, Nabauer M. Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies. Physiol Genomics 34: 88-94, 2008.
26. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardio-myopathy by prolonged mechanical unloading. Circulation 91: 2717-2720, 1995.
27. Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 104: 1147-1152, 2001.
28. Liang H, Muller J, Weng YG, Wallukat G, Fu P, Lin HS, Bartel S, Knosalla C, Pregla R, Hetzer R. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy. Chin Med J (Engl) 117: 401-407, 2004.
29. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98: 2383-2389, 1998. (Pubitemid 28549781)
30. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96: 592-599, 2005.
31. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 59: 609-613, 1995.
32. Milting H, El Banayosy A, Kassner A, Arusoglu L, Körfer R. Analysis of the unloaded heart from patients suffering from dilated cardiomyopathy and supported by ventricular assist devices using cDNA arrays (Abstract). Circulation 102: II763, 2000.
33. Milting H, Ellinghaus P, D'Urso D, Seewald M, Cebulla R, Kassner A, Arusolgu L, Morshuis M, Körfer R, El-Banayosy A. Whole transcriptome analysis of heart transplantation candidates supported by pulsatile and non-pulsatile ventricular assist devices. J Heart Lung Transplant 26: S208, 2007.
34. Milting H, Ellinghaus P, Seewald M, Cakar H, Bohms B, Kassner A, Korfer R, Klein M, Krahn T, Kruska L, El Banayosy A, Kramer F. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 27: 589-596, 2008.
35. Milting H, Jacob M, Kassner A, Heimann P, Mannherz HG, Becker G, Meyer HE, Bothig D, Arusoglu L, Morshuis M, Korfer R, El Banayosy A. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant 23: 396-404, 2004.
36. Milting H, Kassner A, Arusoglu L, Meyer HE, Morshuis M, Brendel R, Klauke B, El Banayosy A, Korfer R. Influence of ACE-inhibition and mechanical unloading on the regulation of extracellular matrix proteins in the myocardium of heart transplantation candidates bridged by ventricular assist devices. Eur J Heart Fail 8: 278-283, 2006. (Pubitemid 43674485)
37. 2+-dependent ATPase-activity in left ventricular myocardium during mechanical circulatory support. J Heart Lung Transplant 22: 1209-1216, 2003.
38. Milting H, Scholz C, Arusoglu L, Freitag M, Cebulla R, Jaquet K, Korfer R, DVL, Kassner A, Brodde OE, Kogler H, El Banayosy A, Pieske B. Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol 41: 441-450, 2006.
39. Muller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96: 542-549, 1997. (Pubitemid 27329431)
40. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kuhl U, Schultheiss HP. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99: 2750-2756, 1999.
41. Seewald MJ, Ellinghaus P, Kassner A, Stork I, Barg M, Niebrugge S, Golz S, Summer H, Zweigerdt R, Schrader EM, Feicht S, Jaquet K, Reis S, Korfer R, Milting H. Genomic profiling of developing cardiomyocytes from recombinant murine embryonic stem cells reveals regulation of transcription factor clusters. Physiol Genomics 38: 7-15, 2009.
42. Steenman M, Chen YW, Le Cunff M, Lamirault G, Varro A, Hoffman E, Leger JJ. Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 12: 97-112, 2003.